Molecular Diagnostics Market

Brandessence Market Research is working on a new report title “Global Molecular Diagnostics Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025.  Increasing number of chronic & infectious diseases and technological advancements are key drivers for Global Molecular Diagnostics Market.

Scope of Global Molecular Diagnostics Market Reports –

The term “molecular diagnostics” refers to clinical tests used to identify a disease or the susceptibility to a disease, by analyzing DNA / RNA or their proteins, in humans or in the case of infections, in microbes. Its scope includes the clinical testing devices, as well as their reagents and supplies that are utilized in hospitals, clinics, commercial laboratories, reference laboratories and research institutes to detect cells and proteins for the purpose of diagnosis and monitoring disease. Molecular diagnostics play an important role in infectious disease testing as they provide effective and fast results. So, during the study of Global Molecular Diagnostics Market, we have considered global molecular diagnostics products and consumables to analyze the market.

Global molecular diagnostics market report is segmented on the basis of product, technology, application and end user. Based on product global molecular diagnostics market is classified as instruments, reagents and services. Based upon technology, global molecular diagnostics market is classified as PCR (Polymerase Chain Reaction), INAAT (Isothermal Nucleic Acid Amplification Technology), DNA sequencing, hybridization, microarray and others. Based upon applications, global molecular diagnostics market is classified as infectious diseases, chronic diseases, genetic testing, screening and pharmacogenomics. Based upon end user type, global molecular diagnostics market is classified as hospitals, laboratories and research institutes.
The regions covered in this global molecular diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Global Molecular Diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Molecular Diagnostics Market Reports-

Global molecular diagnostics market report covers prominent play Bio-Rad Laboratories, Inc., Abbott, Siemens Healthcare GmbH, Alere, Inc., Dako, Bayer AG, Hologic, Inc., Danaher, Sysmex Corporation, Novartis AG, Johnson & Johnson, Qiagen N.V., Becton Dickinson and Company, Roche Diagnostics, BioMerieux SA, Cepheid, Quidel Corporation, Debiopharm Group, Onkogen Diagnostik Sistemler Ltd., Myriad Genetics, Genomic Health, Luminex, GenMark Diagnostics, Biocartis Group and others.

Global Molecular Diagnostics Market Dynamics –

Increasing number of chronic diseases such as cancer, cardiovascular disease, diabetes, pulmonary respiratory diseases, arthritis have led to the growth of the molecular diagnostics market. Moreover, rise in awareness among people, demand for early diagnostics of diseases, improving healthcare facilities and technological advancements are majorly responsible for the continuous growth of the molecular diagnostics market. According to World Health Organization, infectious diseases kill over 17 million people a year. However, high costs and regulatory hurdles in approval process are the major restrains of the Global Molecular Diagnostics Market. Nonetheless, untapped market and technological advancements may generate new opportunities in forecast period.

Global Molecular Diagnostics Market Regional Analysis –

North America dominates the market with highest market share due to increase in funding by governments and different organizations, rise in number of cases of infectious and chronic diseases and increase in awareness of personalized medicines. In U.S, every year, around 1.7 million Hospital Acquired Infections (HAIs) are encountered, resulting in 99,000 deaths and costing an estimated USD 20 billion. Availability of robust healthcare infrastructure in this region has boosted the demand for molecular diagnostics

Europe is the second largest market for global molecular diagnostics. Increasing prevalence of chronic diseases, increasing healthcare expenditure, growing awareness among people, extensive research and development activities are majorly responsible on growth of Global Molecular Diagnostics Market in Europe. According to National Statistics, total current healthcare expenditure of UK in 2016 was around 253.9 billion USD. The rising demand for point-of-care and rapid testing, primarily blood glucose testing, and the strong government support to promote early disease detection to prevent ill-health are some of the major factors driving the molecular diagnostics market in UK.

Asia Pacific region is showing robust growth in Global Molecular Diagnostics Market due to increasing population, rising disposable income among the population, high incidences of chronic diseases and infectious diseases and improving healthcare infrastructure. Non-communicable diseases (NCDs) are the critical cause of disease burden and mortality in the Asia Pacific region, claiming 55% of total life in the South East Asia region each year and 75% in the Western Pacific region.
Key Benefits for Global Molecular Diagnostics Market Reports –

Global Molecular Diagnostics Market report covers in depth historical and forecast analysis.
Global Molecular Diagnostics Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Molecular Diagnostics Market report helps to identify opportunities in market place.
Global Molecular Diagnostics Market report covers extensive analysis of emerging trends and competitive landscape.
Molecular Diagnostics Market Segmentation –
By Product 

Instruments
Reagents
Services
By Technology

PCR (Polymerase Chain Reaction)
INAAT (Isothermal Nucleic Acid Amplification Technology)
DNA Sequencing
Hybridization
Microarray
Others
By Application

Infectious Diseases
Chronic Diseases
Genetic Testing
Screening
Pharmacogenomics
By End User 

Hospitals
Laboratories
Research Institutes
By Region

North America
U.S.
Mexico
Canada
Europe
UK
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
The Middle East and Africa
GCC
Africa
Rest of Middle East and Africa 
Molecular Diagnostics Market Key Players
Bio-Rad Laboratories, Inc.
Abbott
Siemens Healthcare GmbH
Alere, Inc.
Dako
Bayer AG
Hologic, Inc.
Danaher
Sysmex Corporation
Novartis AG
Bio-Rad Laboratories, Inc.
Abbott
Siemens Healthcare GmbH
Alere, Inc.
Dako
Bayer AG
Hologic, Inc.
Danaher
Sysmex Corporation
Novartis AG
Johnson & Johnson
Qiagen N.V.
Becton Dickinson and Company
Roche Diagnostics
BioMerieux SA
Quidel Corporation
BioMerieux, Inc.
Debiopharm Group
Onkogen Diagnostik Sistemler Ltd.
Myriad Genetics
Genomic Health
Luminex
GenMark Diagnostics
Biocartis Group
Foundation Medicine
Others

Interested in this report?

Get your sample now!

Download Sample